Tamer Khayal
Fortuna: 1 M $ al 31/05/2026
Fortuna: 1 M $ al 31/05/2026
Tamer I.
Khayal is Chief Medical Officer at TransMedics, Inc. since 2013 and Senior Vice President-International at TransMedics Group, Inc. starting in 2026.
Formerly, Dr. Khayal was Director-Clinical Affairs at Zentiva Group.
Education includes a doctorate from KasrAlAiny School of Medicine conferred in 1993.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
TRANSMEDICS GROUP, INC. 0,04 % | 31/03/2026 | 15.038 ( 0,04 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TRANSMEDICS GROUP, INC. | Corporate Officer/Principal | 01/01/2018 |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Director Técnico/Científico/I+D | 01/05/2001 |
| Empresas | Cargo | Fin |
|---|---|---|
Zentiva Group as
Zentiva Group as Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets generics & pharmaceutical products | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Zentiva Group as
Zentiva Group as Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets generics & pharmaceutical products | Health Technology |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Health Technology |
KasrAlAiny School of Medicine
KasrAlAiny School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransMedics Group, Inc.
TransMedics Group, Inc. Medical SpecialtiesHealth Technology Manufactures portable electromechanical medical devices for organ transplantation of end-stage organ failure patients | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.